Replies to post #54635 on NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Would it be correct to say that if they did use the 1st interim as an efficacy look beyond the DMC, that it would be an un-planned alpha-spend, and would thus lower the chance of approval both at the second interim and at full planned trial length, if such proved necessary? ...Thus it would be a gamble.